Published Ahead-of-Print - Last Updated: May 22, 2018

The editors of this journal are pleased to offer electronic publication of accepted papers prior to print publication. These papers can be cited using the date of access and the unique DOI number. Any final changes in manuscripts will be made at the time of print publication and will be reflected in the final electronic version of the issue.

Disclaimer: Articles appearing in this Published Ahead-of-Print section have been peer-reviewed and accepted for publication in this journal and posted online before print publication. Articles appearing here may contain statements, opinions, and information that have errors in facts, figures, or interpretation. Accordingly, Lippincott Williams & Wilkins, the editors and authors and their respective employees are not responsible or liable for the use of any such inaccurate or misleading data, opinion or information contained in the articles in this section.

Published Ahead-of-Print Articles are available in PDF format only.


PDF Only


Tumour-infiltrating lymphocytes, programmed death ligand 1 and cyclooxygenase-2 expression in skin melanoma of elderly patients: clinicopathological correlations

Iacono, Donatella; Cinausero, Marika; Gerratana, Lorenzo; More

Melanoma Research. ., Post Author Corrections: May 22, 2018

High baseline neutrophil-to-lymphocyte ratio predicts worse outcome in patients with metastatic BRAF-positive melanoma treated with BRAF and MEK inhibitors

Teterycz, Pawel; Jagodzinska-Mucha, Paulina; Cybulska-Stopa, Bozena; More

Melanoma Research. ., Post Author Corrections: May 18, 2018

Epidemiological trends in the diagnosis of melanoma in a Southern European population: analysis of a large database from a tertiary referral center

Tsoutsos, Dimosthenis; Papadopoulos, Stefanos; Kehagias, George; More

Melanoma Research. ., Post Author Corrections: May 14, 2018

Vemurafenib in BRAF-mutant metastatic melanoma patients in real-world clinical practice: prognostic factors associated with clinical outcomes

Schouwenburg, Maartje G.; Jochems, Anouk; Leeneman, Brenda; More

Melanoma Research. ., Post Author Corrections: May 10, 2018

The impact of patient characteristics and disease-specific factors on first-line treatment decisions for BRAF-mutated melanoma: results from a European expert panel study

Ascierto, Paolo A.; Bastholt, Lars; Ferrucci, Pier F.; More

Melanoma Research. ., Post Author Corrections: May 10, 2018

Targeted ultrasound and fine-needle aspiration cytology for sentinel node diagnostics in early-stage melanoma: a validation study

Ternov, Niels K.; Lambine, Trine-Lise; Wagenblast, Anne L.H.; More

Melanoma Research. ., Post Author Corrections: March 27, 2018


PDF Only


Early onset of diffuse melanosis cutis under pembrolizumab therapy illustrates the limitations of anti-PD-1 checkpoint inhibitors

Thiem, Alexander; Schummer, Patrick; Ueberschaar, Simon; More

Melanoma Research. ., Post Author Corrections: May 17, 2018